Wakasa M - Search Results

1

Long-Term Effect of Denosumab on Bone Disease in Patients with CKD.

Iseri K, Mizobuchi M, Winzenrieth R, Humbert L, Saitou T, Kato T, Nakajima Y, Wakasa M, Shishido K, Honda H. Iseri K, et al. Among authors: wakasa m. Clin J Am Soc Nephrol. 2023 Sep 1;18(9):1195-1203. doi: 10.2215/CJN.0000000000000213. Epub 2023 Jun 14. Clin J Am Soc Nephrol. 2023. PMID: 37314764 Free PMC article.

2

Treatment of hyperphosphatemia with bixalomer in Japanese patients on long-term hemodialysis with gastrointestinal symptoms.

Ito K, Takeshima A, Shishido K, Wakasa M, Kumata C, Matsuzaka K, Nakajima Y, Ogata H. Ito K, et al. Among authors: wakasa m. Ther Apher Dial. 2014 Jun;18 Suppl 2:19-23. doi: 10.1111/1744-9987.12229. Ther Apher Dial. 2014. PMID: 24975891

3

Bone density of the femoral neck in patients on maintenance dialysis.

Nakanishi K, Shishido K, Kumata C, Ito K, Nakashima Y, Wakasa M. Nakanishi K, et al. Among authors: wakasa m. PLoS One. 2018 May 24;13(5):e0197965. doi: 10.1371/journal.pone.0197965. eCollection 2018. PLoS One. 2018. PMID: 29795652 Free PMC article.

4

Effect of dialysis membranes and ACE inhibitor on bradykinin levels during hemodialysis.

Akizawa T, Kinugasa E, Wakasa M, Kohjiro S, Koiwa F, Koshikawa S. Akizawa T, et al. Among authors: wakasa m. Clin Nephrol. 1994 Apr;41(4):241-4. Clin Nephrol. 1994. PMID: 8026119 Clinical Trial.

5

Randomized controlled open-label trial of vitamin E-bonded polysulfone dialyzer and erythropoiesis-stimulating agent response.

Sanaka T, Mochizuki T, Kinugasa E, Kusano E, Ohwada S, Kuno T, Kojima K, Kobayashi S, Satoh M, Shimada N, Nakao K, Nakazawa R, Nishimura H, Noiri E, Shigematsu T, Tomo T, Maeda T; VEESA Study Group. Sanaka T, et al. Clin J Am Soc Nephrol. 2013 Jun;8(6):969-78. doi: 10.2215/CJN.04680512. Epub 2013 Apr 18. Clin J Am Soc Nephrol. 2013. PMID: 23599410 Free PMC article. Clinical Trial.

6

Plasma bradykinin levels during hemodialysis with PAN DX and polysulfone membranes with and without concurrent ACE inhibitor.

Wakasa M, Akizawa T, Kinugasa E, Koshikawa S. Wakasa M, et al. Clin Nephrol. 1995 Nov;44 Suppl 1:S29-32. Clin Nephrol. 1995. PMID: 8608658 Clinical Trial.

7

Nafamostat as anti-coagulant for membrane plasmapheresis in high bleeding risk patients.

Kinugasa E, Akizawa T, Nakashima Y, Wakasa M, Koshikawa S. Kinugasa E, et al. Among authors: wakasa m. Int J Artif Organs. 1992 Oct;15(10):595-600. Int J Artif Organs. 1992. PMID: 1428207

8

Initial decrease in the lipoprotein(a) level is a novel prognostic biomarker in patients with acute coronary syndrome.

Saeki Y, Sawaguchi J, Akita S, Takamura TA, Fujibayashi K, Wakasa M, Akao H, Kitayama M, Kawai Y, Kajinami K. Saeki Y, et al. Among authors: wakasa m. World J Cardiol. 2024 Jun 26;16(6):329-338. doi: 10.4330/wjc.v16.i6.329. World J Cardiol. 2024. PMID: 38993583 Free PMC article.

9

Health literacy in older patients with abdominal tumours and its association with clinical characteristics: A cross-sectional study.

Iwakura M, Kawagoshi A, Furukawa Y, Sugawara K, Wakabayashi T, Sato T, Wakasa M. Iwakura M, et al. Among authors: wakasa m. Eur J Oncol Nurs. 2023 Dec;67:102461. doi: 10.1016/j.ejon.2023.102461. Epub 2023 Nov 7. Eur J Oncol Nurs. 2023. PMID: 37976753

10

Thrombotic Microangiopathy after a 15-year Treatment with Interferon Beta-1b in a Patient with Multiple Sclerosis: A Case Report and Review of Literature.

Akita S, Fujibayashi K, Ueno EI, Wakasa M, Kawai Y, Kajinami K. Akita S, et al. Among authors: wakasa m. Intern Med. 2024 Apr 15;63(8):1113-1117. doi: 10.2169/internalmedicine.1846-23. Epub 2023 Sep 1. Intern Med. 2024. PMID: 37661454 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters